Tyrone Miller - 21 Nov 2023 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 May 2024, 20:22:13 UTC
Prior SEC filing
12 Jul 2023
Next SEC filing
24 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tyrone Miller

Key filing fact

Tyrone Miller filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 21 May 2024.

Key facts

  • This page summarizes Tyrone Miller's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
  • 5 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 21 May 2024, 20:22.

Change

  • Previous filing in this sequence was filed on 12 Jul 2023.
  • Current net transaction value: +$19,353.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SXTP transaction

Common Stock

Award

Transaction value
$16,008
Shares
+60,000
Change %
+59%
Price
$0.2668
Shares after
161,928
Date
12 Apr 2024
Ownership
Direct
Footnotes
F1
SXTP transaction

Common Stock

Award

Transaction value
$3,345
Shares
+15,000
Change %
+9.3%
Price
$0.2230
Shares after
176,928
Date
16 May 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SXTP transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+75,000
Change %
Price
$0.000000
Shares after
75,000
Date
21 Nov 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$0.000000
Footnotes
F3
SXTP transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-60,000
Change %
-80%
Price
$0.000000
Shares after
15,000
Date
12 Apr 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$0.000000
Footnotes
F3, F4
SXTP transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-15,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
16 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$0.000000
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Tyrone Miller was granted a total of 75,000 restricted stock units ("RSUs") on November 21, 2023 that were fully vested as of the grant date. 60,000 shares underlying the RSUs were settled on April 12, 2024 (the "4/24 Shares"). Tyrone Miller owned 101,928 shares of common stock immediately prior to the issuance of the 4/24 Shares. As of April 12, 2024, Tyrone Miller owned a total of 161,928 shares of common stock.

Footnote F2

15,000 shares underlying the RSUs were settled on May 16, 2024 (the "5/24 Shares"). Tyrone Miller owned 161,928 shares of common stock immediately prior to the issuance of the 5/24 Shares. As of May 16, 2024, Tyrone Miller owned a total of 176,928 shares of common stock.

Footnote F3

Tyrone Miller was granted a total of 75,000 restricted stock units on November 21, 2023 that were fully vested as of the grant date. Each RSU represents the right to receive, at settlement, one share of common stock.

Footnote F4

60,000 shares underlying the RSUs were settled on April 12, 2024. After the settlement of the shares of common stock that were underlying the 60,000 RSUs, Tyrone Miller owned a total of 15,000 RSUs.

Footnote F5

15,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 15,000 RSUs, Tyrone Miller did not own any RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .